Some thoughts on Biologics

By Leslie Sunday, January 27, 2013

Right up front here, let me make clear that I am far from an expert on this subject. In fact, I'm just beginning to learn about these biotech miracles and what I have discovered for myself has been both frightening and exciting. I guess it's a little like deciding to go to the moon. Worth the trip? Heck, yea! Without risk? Heck, no! I started Humira in September of last year and while methotrexate had helped me some providing me hope where I had none, Humira was a simple miracle. Within days, my pain and stiffness began to disappear; where every joint was painful and stiff, I could now count the on one hand (with actual moving fingers!) the number of joints that had pain and that pain was very tolerable. The injections took some getting used to, true, but now they just aren't that big of a deal. I can shake hands without pain. I can get out bed reasonably well. My stiffness is down to maybe 15 or 30 minutes in the morning as opposed to hours. And I could expect continued improvement!

 

Then, bang! Bronchitis! Now, we all know that biologics come with a long list of warnings and high on that list is an increased risk of infection. Afterall, what we are doing is slapping down our immune system to stop it from attacking our joints (and anything else it can find) and this can sometimes make us more open to infection, especially upper respritory infection. So, I go off to urgent care for breathing treatments, antibiotics, inhalers and cough meds. And I stop my Humira and MTX and the joint pain comes back. When the bronchitis is better, I'm back on my arthritis meds and the joints start feeling better and bang - bronchitis again - same sequence! Second time 5 months. Not good.

 

So off to my rheumatologist I go and we have a chat about this. I'm doing well on the Humira, my inflammation numbers are down, my anemia is improving, my liver numbers are holding their own and my joints are happy, happy, but I am having trouble staying on it because of the infections. This has been a hard winter for everyone with lots of upper respritory infections so it's possible that I won't continue at this rate. We decide to give it another 4 to 6 months and see if I continue to get sick or if I manage to stay well and on the medication. If my rate of infection continues, we will try switching to Enbrel.

 

Enbrel has a lower rate of infection than Humira does. Did you know this? I sure didn't! If you look at their websites it would be very difficult to discover the actual clinical rate of infection or do a comparison. After this conversation though, I did some research and there is some data that compares the different biologics and their infection risk and there is a real difference. Of course, this isn't the only thing that would guide our choices when we are trying to decide what biologic to try. If I were to select the safest biologic it would be of no use if it weren't effective for me and sometimes a biologic that works for one person won't work for another.

Lene Andersen, Health Guide
1/30/13 1:10pm

First, I need to do a solid (and loud) Yippieee!! that you found a medication that works for you! Managing infection risk is a balancing act, but it sounds as if you and your doctor have a good plan.

 

I had no idea that there were varying infection rates on the different meds — if you still have the URL for the article, would you mind sending it to me? I'd be very interested in following up on this.

 

I do think this winter has been particularly awful for almost everyone and not just people with RA. I just came from my doctor's office (went to get my shot of Humira) and there was not one empty chair. I assume you've had the flu and pneumonia vaccines? If not, please do those two, plus a tetanus vaccine are must-haves for those of us who are on Biologics.

 

Please keep us posted on your progress.

2/ 2/13 11:13am

Lene,

 

The first place I encountered anything that actually talked about one TNF having a different rate of infection than another was when I clicked on a CME link from the MedPage Today newsletter. I had signed up for the newsletter as a patient interested in rheumatology and I get email from MedPage - part of Medline. You have to be a member but you can be without being a medical professional. Turns out you can also take the CME class too! (You just can't get CMEs, lol!) Anyway, I could forward the email and you could try the CME presentation - it was Balancing Evidence and the Art of Clinical Practice: Evolving Strategies in the Targeted Approach to Treating Patients with Rheumatoid Arthritis. He referenced the British study that had previously stated that there was no significant difference between the (at the time of the study, 3) TNF inhibitors but in the new study there is a slight difference favoring Enbrel for safety. Like I said, it really doesn't do us any good if it doesn't work for us, but it might influence our first choice.

 

My rheumatologist said to me that Enbrel has a lower infection risk that Humira. This matched what the presentation said. I also scanned some scholarly hits on google - you get a wide mix. Most of the lot don't do any direct comparison but evaluate safety overall or indivually. That's why I was commenting on how nice it would be to have a good comparison. In this brave new world of the empowered patient, we are given some partial information and asked to make an "informed" decision. Really how informed is it?

Lene Andersen, Health Guide
2/ 6/13 10:21am

Thanks for the tip! I've signed up.

V, Health Guide
2/ 3/13 11:17pm

This is a great article, Leslie.  Thank you so much for sharing this.  Would be really interesting if we could find infection rates for all the bios.  Maybe they don't want to make it easy for us...???

 

Blessings,

V

2/ 4/13 8:27am

I was trying to figure out a way to share the CME presentation. It was interesting and not really hard to follow considering it was directed towards rheumatologists. I finally used my Camptasia software to record the whole thing. I'm fairly sure that wide distribution would be a violation of copywrite of some sort but if I can send it to an email, it's worth watching.

 

My experience with getting information on ACR results or infection rates on biologics at least in terms of actual hard numbers, the results of their trials, is that they are rather difficult to come by on the drug maker's sites. Comparison data is even more difficult to get but there haven't been a lot of comparative studies done just yet. The researchers are learning about these drugs as we are. 10 years ago there wasn't 10 years worth of data to work with. We are the test subjects, like it or not. I've always had an interest in science and find the whole thing remarkable but would wonder how many rheumatologists are staying up to date on all the latest on these meds.

2/ 4/13 5:03pm

Hi Leslie,

 

Thanks for this. Like everyone else, I had no idea that there were different rates of infection. It makes sense though when you think about it... different biologics and all, but it was never a thought that had crossed my mind.

 

Thanks again,

Ish

Ask a Question

Get answers from our experts and community members.

Btn_ask_question_med
View all questions (3631) >
By Leslie— Last Modified: 02/06/13, First Published: 01/27/13